πŸš€ Exciting News! Pharmidex Launches Comprehensive Histology Services! πŸ”¬βœ¨
March 6, 2025

We’re expanding our capabilities with state-of-the-art histotechnology, delivering high-quality, rapid tissue analysis across dermatology, respiratory, toxicology, oncology, and CNS research.


πŸ”Ž What We Offer:

βœ… High-Throughput Processing – Fast & reliable for large sample volumes

βœ… Expert Paraffin Embedding & Sectioning – Precision tissue preservation

βœ… Advanced Staining & Immunohistochemistry – Routine & specialized stains for in-depth analysis

βœ… Digital Imaging & Slide Scanning – High-resolution visualizations for detailed examination


⚑ Why Choose Pharmidex?

βœ”οΈ Cutting-edge technology

βœ”οΈ Stringent quality control

βœ”οΈ Seamless sample-to-slide traceability


Let’s advance histology together! Get in touch to explore how we can support your research.


πŸ”— Learn more: pharmidex.com/histology

#Pharmidex #Histology #TissueAnalysis #DrugDiscovery #LifeSciences #Innovation

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 30, 2025
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
July 28, 2025
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. πŸ‘©‍πŸ”¬ πŸ‘¨‍πŸ”¬ Welcome to the team, Gabrielle and Mohammed!
BATA Taste Aversion
July 24, 2025
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: βœ… Bitter-tasting APIs βœ… Unpalatable excipients βœ… The success of taste-masking strategies βœ… Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
More Posts